1. Home
  2. LNTH vs ATI Comparison

LNTH vs ATI Comparison

Compare LNTH & ATI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • ATI
  • Stock Information
  • Founded
  • LNTH 1956
  • ATI 1960
  • Country
  • LNTH United States
  • ATI United States
  • Employees
  • LNTH N/A
  • ATI N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ATI Steel/Iron Ore
  • Sector
  • LNTH Health Care
  • ATI Industrials
  • Exchange
  • LNTH Nasdaq
  • ATI Nasdaq
  • Market Cap
  • LNTH 7.5B
  • ATI 7.3B
  • IPO Year
  • LNTH 2015
  • ATI N/A
  • Fundamental
  • Price
  • LNTH $80.24
  • ATI $73.49
  • Analyst Decision
  • LNTH Strong Buy
  • ATI Strong Buy
  • Analyst Count
  • LNTH 5
  • ATI 8
  • Target Price
  • LNTH $133.80
  • ATI $73.29
  • AVG Volume (30 Days)
  • LNTH 1.2M
  • ATI 2.2M
  • Earning Date
  • LNTH 05-07-2025
  • ATI 05-01-2025
  • Dividend Yield
  • LNTH N/A
  • ATI N/A
  • EPS Growth
  • LNTH N/A
  • ATI 2.35
  • EPS
  • LNTH 3.53
  • ATI 2.76
  • Revenue
  • LNTH $1,536,699,000.00
  • ATI $4,463,600,000.00
  • Revenue This Year
  • LNTH $5.81
  • ATI $7.17
  • Revenue Next Year
  • LNTH $12.26
  • ATI $8.41
  • P/E Ratio
  • LNTH $23.15
  • ATI $25.91
  • Revenue Growth
  • LNTH 12.53
  • ATI 6.82
  • 52 Week Low
  • LNTH $74.34
  • ATI $39.23
  • 52 Week High
  • LNTH $126.89
  • ATI $72.28
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 30.10
  • ATI 81.67
  • Support Level
  • LNTH $78.92
  • ATI $51.80
  • Resistance Level
  • LNTH $108.91
  • ATI $72.33
  • Average True Range (ATR)
  • LNTH 3.70
  • ATI 2.61
  • MACD
  • LNTH -2.94
  • ATI 2.07
  • Stochastic Oscillator
  • LNTH 9.74
  • ATI 90.99

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

Share on Social Networks: